Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v6-EN
Language English English
Date Updated 2017-07-07 2017-04-13
Drug Identification Number 02282275 02282275
Brand name MYLAN-RISPERIDONE MYLAN-RISPERIDONE
Common or Proper name RISPERIDONE Risperidone
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients RISPERIDONE RISPERIDONE
Strength(s) 2.0MG 2.0MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100BT 100
ATC code N05AX N05AX
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2017-06-11 2017-07-05
Actual start date 2017-07-06
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments